Two Sigma Investments’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-28,000
| Closed | -$827K | – | 3434 |
|
|
2025
Q1 | $827K | Sell |
28,000
-104,560
| -79% | -$3.09M | ﹤0.01% | 2229 |
|
|
2024
Q4 | $3.85M | Buy |
132,560
+2,465
| +2% | +$71.7K | 0.01% | 1216 |
|
|
2024
Q3 | $5.98M | Sell |
130,095
-95,651
| -42% | -$4.39M | 0.01% | 951 |
|
|
2024
Q2 | $9.22M | Sell |
225,746
-21,554
| -9% | -$880K | 0.02% | 698 |
|
|
2024
Q1 | $6.31M | Sell |
247,300
-420,233
| -63% | -$10.7M | 0.01% | 805 |
|
|
2023
Q4 | $6.04M | Buy |
667,533
+104,191
| +18% | +$943K | 0.01% | 834 |
|
|
2023
Q3 | $3.59M | Buy |
563,342
+48,521
| +9% | +$310K | 0.01% | 1004 |
|
|
2023
Q2 | $5.71M | Buy |
514,821
+186,333
| +57% | +$2.07M | 0.01% | 813 |
|
|
2023
Q1 | $5.04M | Buy |
328,488
+221,588
| +207% | +$3.4M | 0.01% | 858 |
|
|
2022
Q4 | $2.37M | Buy |
106,900
+86,491
| +424% | +$1.92M | 0.01% | 1180 |
|
|
2022
Q3 | $333K | Buy |
+20,409
| New | +$333K | ﹤0.01% | 1880 |
|
|
2021
Q4 | – | Sell |
-13,900
| Closed | -$342K | – | 3041 |
|
|
2021
Q3 | $342K | Buy |
+13,900
| New | +$342K | ﹤0.01% | 2141 |
|